Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01356277 · ClinicalTrials.gov registry record · NA

Intervention to Improve Adherence in Teen Kidney Transplant

A NA study of Medication Adherence and Kidney Transplantation, sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre.

Completed
Registry status
NA
Development phase
170
Enrollment target
8
Study locations

NCT01356277 is a NA study of Medication Adherence and Kidney Transplantation that has completed, run by McGill University Health Centre/Research Institute of the McGill University Health Centre. The registered enrollment target is 170 participants, below the 1,654-participant average among 52 other Medication Adherence trials with a reported enrollment target (90% lower). The trial reports 8 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01356277, a NA study of Medication Adherence and Kidney Transplantation, has completed, sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre.

COMPLETED
Registry status
NA
Development phase
170 participants
Enrollment target
8
Study locations

Study Summary

The broad aim of the proposed study is to improve medication adherence in adolescent kidney transplant recipients. The investigators hypothesize that a multi-component intervention will improve medication adherence in the adolescent kidney transplant population. The specific aims are to determine, in a randomized clinical trial, the efficacy of a structured, multi-component intervention in improving adherence to anti-rejection medications and graft outcomes, and to identify characteristics of healthcare systems that are independently associated with adherence.

Interventions

  • BEHAVIORAL Action-focused problem-solving
  • DEVICE Electronic pillbox monitoring, dose reminders, and feedback

Study Locations (8)

Quebec

  • Montreal Children's Hospital - Montreal
  • St. Justine's Hospital - Montreal

Missouri

  • Washington University School of Medicine - St Louis

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati

Pennsylvania

  • The Children's Hospital of Philadelphia - Philadelphia

Washington

  • Seattle Children's Hospital - Seattle

British Columbia

  • British Columbia Children's Hospital - Vancouver

Ontario

  • University of Toronto Hospital for Sick Children - Toronto

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2012-02
Est. Completion 2016-06
Phase NA

What the Registry Record Tells You About NCT01356277

The ClinicalTrials.gov registry entry for NCT01356277 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,654-participant average among 52 other Medication Adherence trials with a reported enrollment target (90% lower). The listed sponsor is McGill University Health Centre/Research Institute of the McGill University Health Centre, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Medication Adherence appearing as the primary indexed condition, and to 2 interventions - of which Action-focused problem-solving is the first listed.

NCT01356277 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Quebec, Missouri, Ohio.

Frequently Asked Questions

What is clinical trial NCT01356277 about?

NCT01356277 is a clinical study titled "Intervention to Improve Adherence in Teen Kidney Transplant". The broad aim of the proposed study is to improve medication adherence in adolescent kidney transplant recipients. The investigators hypothesize that a multi-component intervention will improve medication adherence in the adolescent kidney transplant population. The specific aims are to determine, i...

What is the current status of trial NCT01356277?

This trial is currently completed. It is a NA study. The enrollment target is 170 participants. The study started on 2012-02. Estimated completion is 2016-06.

What conditions does trial NCT01356277 study?

This clinical trial studies the following conditions: Medication Adherence, Kidney Transplantation.

What interventions are being tested in trial NCT01356277?

The interventions under investigation include: Action-focused problem-solving (BEHAVIORAL), Electronic pillbox monitoring, dose reminders, and feedback (DEVICE).

Who is sponsoring clinical trial NCT01356277?

This trial is sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01356277 being conducted?

This trial has 8 study locations across Missouri, Ohio, Pennsylvania, Washington, British Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Medication Adherence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.